Lobbying client
ADAMAS PHARMACEUTICALS
pharmaceutical company
Filings
20
Filed by
1
Reported in-house
—
Reported by firms
$250,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2008 to 2011
Filings
20 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination Amendment (No Activity) 2nd Quarter 2011
|
FOLEY HOAG LLP | — reported |
|
2nd Quarter - Termination (No Activity)replaced 2nd Quarter 2011
|
FOLEY HOAG LLP | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2011
|
FOLEY HOAG LLP | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2010
|
FOLEY HOAG LLP | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2010
|
FOLEY HOAG LLP | — reported |
|
2nd Quarter - Report 2nd Quarter 2010
|
FOLEY HOAG LLP | — reported |
|
1st Quarter - Report 1st Quarter 2010
|
FOLEY HOAG LLP | — reported |
|
4th Quarter - Report 4th Quarter 2009
|
FOLEY HOAG LLP | $10,000 reported |
|
3rd Quarter - Report 3rd Quarter 2009
|
FOLEY HOAG LLP | $45,000 reported |
|
2nd Quarter - Report 2nd Quarter 2009
|
FOLEY HOAG LLP | $45,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| FOLEY HOAG LLP | 13 | $250,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 10 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.